Mosapramine

Mosapramine

Clinical data
Trade names	Cremin (クレミン, JP)
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral (tablets, oral solution)
ATC code	N05AX10 (WHO)
Legal status
Legal status	Rx-only (JP)
Identifiers
IUPAC name 1'-[3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl]spiro[1,5,6,7,8,8a-hexahydroimidazo[1,2-a]pyridine-3,4'-piperidine]-2-one
CAS Number	89419-40-9 Y
PubChem CID	4257
DrugBank	DB13676
ChemSpider	4107
UNII	04UZQ7O9SJ
KEGG	D08235 Y
CompTox Dashboard (EPA)	DTXSID0048846
Chemical and physical data
Formula	C28H35ClN4O
Molar mass	479.07 g·mol−1
3D model (JSmol)	Interactive image
SMILES C1CCN2C(C1)NC(=O)C23CCN(CC3)CCCN4C5=CC=CC=C5CCC6=C4C=C(C=C6)Cl
InChI InChI=1S/C28H35ClN4O/c29-23-12-11-22-10-9-21-6-1-2-7-24(21)32(25(22)20-23)16-5-15-31-18-13-28(14-19-31)27(34)30-26-8-3-4-17-33(26)28/h1-2,6-7,11-12,20,26H,3-5,8-10,13-19H2,(H,30,34) Key:PXUIZULXJVRBPC-UHFFFAOYSA-N
(verify)

Mosapramine (Cremin) is an atypical antipsychotic used in Japan for the treatment of schizophrenia. It is a potent dopamine antagonist with high affinity to the D₂, D₃, and D₄ receptors, and with moderate affinity for the 5-HT₂ receptors.

See also

• Carpipramine
• Clocapramine
• Fluspirilene (typical antipsychotic)
• Imidazopyridine